Financings in Brief: Diatide
This article was originally published in The Gray Sheet
Executive Summary
Diatide: Makes initial public offering of 2.2 mil. shares at a price of $8.50 per share. The imaging agent manufacturer projected that the offering would price 2.5 mil. shares at $10 to $12 each in a registration statement for the offering filed with SEC in April ("The Gray Sheet" April 29, p. 18)...